We currently have a range of Global Public Policy Positions, which are available at www.bd.com/investors/ corporate_governance/policy-positions.aspx We also engage in policy dialogue to advance regulatory and reimbursement frameworks that ensure the safety and efficacy of medical technologies, while also enabling timely patient access to them.